Abstract
Small cell lung cancer (SCLC) is the most aggressive subtype of lung cancer with a 5-year survival rate of only 6%, which is mainly attributed to the rapid development of resistance to chemotherapy. Recent investigations reveal that SCLC is a phenotypically highly heterogeneous disease. Nevertheless, the relation between the growth phenotypes and chemo-resistance of SCLC remains largely unclear.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
